Results 101 to 110 of about 766 (173)

LUMIADE 3: Therapeutic Equivalence of Denosumab Biosimilar FKS518 to Reference Product in Postmenopausal Osteoporosis. [PDF]

open access: yesJ Endocr Soc
Krecipro-Nizinska E   +7 more
europepmc   +1 more source

Bespoke science: the use of ad hoc scientific advisory committees in the Covid-19 pandemic. [PDF]

open access: yesPublic Choice
Koppl R   +4 more
europepmc   +1 more source

Population-level evidence on lifestyle-related education and preventive services in primary care in Poland-a 2025 cross-sectional survey. [PDF]

open access: yesFront Public Health
Grudziąż-Sękowska J   +5 more
europepmc   +1 more source

Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47. [PDF]

open access: yesRMD Open
Smolen JS   +19 more
europepmc   +1 more source

Hypertensive patient's journey in Poland. [PDF]

open access: yesBMC Health Serv Res
Szyndler A, Stryczyńska-Lewińska M.
europepmc   +1 more source

Home - About - Disclaimer - Privacy